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Antigen presentation and microbial killing are critical
arms of host defense that depend upon cargo traf-
ficking into lysosomes. Yet, the molecular regulators
of traffic into lysosomes are only partly understood.
Here, using a lysosome-dependent immunological
screen of a trafficking shRNA library, we identified
the Arf-like GTPase Arl8b as a critical regulator of
cargo delivery to lysosomes. Homotypic fusion and
vacuole protein sorting (HOPS) complex members
were identified as effectors of Arl8b and were depen-
dent on Arl8b for recruitment to lysosomes, suggest-
ing that Arl8b-HOPS plays a general role in directing
traffic to lysosomes. Moreover, the formation of
CD1 antigen-presenting complexes in lysosomes,
their delivery to the plasma membrane, and phago-
some-lysosome fusion were all markedly impaired
in Arl8b silenced cells resulting in corresponding
defects in T cell activation and microbial killing.
Together, these results define Arl8b as a key
regulator of lysosomal cellular and immunological
functions.
INTRODUCTION
Intracellular trafficking to and from lysosomes is a key event in
many processes required for host defense. For example, CD1
antigen-presenting molecules bind microbial lipids in lysosomes
and in specialized compartments formed from the fusion of
phagosomes with lysosomes to form phagolysosomes (Hava
et al., 2008; Ramachandra et al., 2009). After synthesis in the
endoplasmic reticulum (ER) and delivery to the cell surface,
CD1 molecules are internalized into the endocytic system where
they bind lipid antigens and then carry them back to the cell
surface to stimulate T cell activation (Cohen et al., 2009).
Previous studies on CD1 trafficking defined tyrosine-based sort-182 Immunity 35, 182–193, August 26, 2011 ª2011 Elsevier Inc.ing motifs in the tails of CD1 isoforms (CD1b, CD1c, and CD1d),
which bind adaptor protein 2 (AP-2) and mediate their internali-
zation into the early endocytic system via clathrin-coated pits.
The tails of CD1b and mCD1d bind adaptor protein 3 (AP-3),
which sorts them into late endosomes and lysosomes (Cernadas
et al., 2003; Chiu et al., 2002; Elewaut et al., 2003). Entry into
lysosomes is critical for access to saposins, which load lipids
into CD1 molecules, and for access to degradative enzymes
that processes microbial lipid antigens (Cohen et al., 2009).
Understanding how trafficking of antigen-presenting mole-
cules is directed to lysosomes and phagolysosomes is critical
to understanding host defense. A number of molecules that drive
the steps involved in vesicular trafficking have been described,
but few have been implicated in regulating lysosomal traffic in
mammalian cells. In yeast, molecules of the vacuole protein
sorting (VPS) class have been described to play a role in traf-
ficking to the vacuole, an organelle analogous to the lysosome.
However, the role of many VPS proteins in mammalian lyso-
somes remains unknown. Small GTPases of the Ras-superfamily
such as Rabs and ADP ribosylation factors (Arfs) serve as the
vesicle ‘‘signposts’’ and organizers of membrane traffic and
help mediate vesicle budding and recruitment of effector
proteins (Behnia and Munro, 2005). For example, Rab7 has
been proposed to control trafficking from late endosomes to
lysosomes through recruitment of effectors that control
a dynein-dynactin motoring apparatus (Zhang et al., 2009).
To identify molecular mediators of lysosomal trafficking, we
developed a shRNA library targeting trafficking molecules
and used it in a screen for loss of lysosome-dependent CD1
antigen-presenting function. Our screen identified Arl8b as a
strong mediator of CD1 trafficking to lysosomes and antigen
presentation.
Arl8b is a small GTPase of the Arl (Arf-like) family. Previous
reports implicate Arl8b in the distribution of lysosomes within
the cytosol (Bagshaw et al., 2006; Hofmann and Munro, 2006).
Here, we identified a role for Arl8b directing endosome to
lysosome trafficking for multiple types of cargo. Arl8b silencing
resulted in a delay in delivery of fluid phase dextran, receptor-
internalized low-density lipoprotein (LDL), and CD1 cargo to
lysosomes. Furthermore, Arl8b was found to bind and recruit
Figure 1. shRNA Silencing of Arl8b
Decreases CD1d Antigen Presentation
(A) Composite data from two sample screening
plates. The number of U937 cells surviving drug
selection (Alamar Blue) was plotted versus the
response of NKT cells (IFN-g). A best fit line was
drawn for each batch of screening plates and
shRNA constructs compared to the line to
measure the effect on CD1d presentation. Exper-
imental shRNAs (red squares), shRNAs targeting
Arl8b (blue triangles), and control shRNAs
included on each screening plate targeting GFP,
RFP, and LacZ (green diamonds) are shown.
(B) Arl8b silenced and control DCs were plated
with aGal-aGalCer in the indicated doses along
with NKT-cell clone BM2a.3. Following overnight
incubation NKT-cell stimulation was assessed by
IFN-g ELISA.
(C) Arl8b silenced and control murine RAW
macrophages were plated with aGal-aGalCer
along with NKT-cell hyrbidoma DN32. Following
overnight incubation DN32 stimulation was as-
sessed by IL-2 ELISA.
(D and E) Immunoblots of U937 (D) or RAW (E)
lysates made in 0.5% Triton blotted with Arl8b
antisera (upper panel) or stripped and reprobed
for loading controls (lower panel). The arrow indi-
cates the position of the dominant band inferred to
be Arl8b, with a Mr of 19.5 kDa based on stan-
dards. The lighter arrow indicates the inferred
position of Arl8a.
(F) HeLa CD1d-expressing cells were stably
transduced with control or shArl8b-407 targeting
shRNA and subsequently transfected with the
construct used in F-containing silent mutations in
the shRNA target sequence, termed ‘‘rescue.’’
aGal-aGalCer lipid was then added at 1 ng/mL
along with BM2a.3 the response measured by
IFN-g ELISA. All error bars indicate standard error
of the mean. See also Figure S1.
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sorting) complex to lysosomes. Arl8b silencing and loss of
HOPS complex subunit recruitment to lysosomes resulted in
a defect in trafficking of CD1 molecules to lysosomes and de-
layed formation of CD1-lipid antigen complexes. Importantly,
phagosome to lysosome delivery and fusion were delayed by
Arl8b silencing resulting in a defect in microbial killing. Together,
these data mark Arl8b as a regulator of endosome to lysosome
trafficking pathways of special significance for host defense.
RESULTS
CD1d Lysosome-Dependent Antigen Presentation
Screen Identifies Arl8b
We built a custom shRNA trafficking library to screen for lyso-
somal dependent antigen presentation by CD1d. CD1d+ U937
myelomonocytic cells were transduced with shRNA and stably
selected with puromycin, then incubated with a(1/2)Gala
GalCer (aGal-aGalCer), a model lipid antigen that requires lyso-somal cleavage of the terminal aGal to reveal the antigenic
epitope aGalCer (Prigozy et al., 2001). We accessed formation
and trafficking of CD1d,aGalCer complexes by measuring
IFN-g secretion from CD1d-restricted aGalCer reactive natural
killer T cells (NKT-cells). By plotting the IFN-g response of
NKT-cells against the number of surviving U937 cells, we can
readily identify wells in which shRNA silencing of a trafficking
molecule negatively impacts NKT-cell activation by reduced
NKT-cell secretion of IFN-g (Figure 1A). For validation of the
shRNA screen, the library included several control shRNA ex-
pected to inhibit aGalCer presentation. Strong reduction in
NKT cell activation was noted for shRNA targeting adaptor
protein-2 (AP-2) and clathrin heavy chain, both of which control
CD1d internalization and for shRNA targeting prosaposin that
yields the lysosomal saposins necessary to transfer lipids to
CD1 (Figure S1 available online).
Importantly, a number of library shRNAs either blocked or
enhanced antigen presentation to NKT cells. Two unique shRNA
sequences targeting Arl8b (Arl8b-346 and Arl8b-407) thatImmunity 35, 182–193, August 26, 2011 ª2011 Elsevier Inc. 183
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secretion from NKT Cells were selected from the screen for
further study (Figure 1A, blue triangles). Given that library
screening was performed with the U937 tumor cell line, we
extended this finding by using primary humanmonocyte-derived
dendritic cells (DCs) as professional antigen-presenting cells
(APCs). APCs were stably transduced with lentivirus expressing
Arl8b-407 shRNA or control shRNA, plated with increasing
doses of aGal-aGalCer lipid antigen, and the response of
primary human NKT-cells (clone BM2a.3) was measured by
IFN-g secretion. Although Arl8b silencing did not change CD1d
at the cell surface, it produced a two-log decrease in dose-
dependent antigen presentation compared to control shRNA
treated DCs (Figure 1B, e.g., the stimulation achieved by
.32 ng/mL aGal-aGalCer in control DCs is achieved only by add-
ing 40 ng/mL aGal-aGalCer in Arl8b-silenced DCs). The maximal
stimulation reached at the highest antigen dose in Arl8b silenced
cells was only 11% of control cells. By comparison, Arl8b
silencing did not alter cell surface expression of CD1a and
showed normal stimulation of CD1a-autoreactive clones, sug-
gesting Arl8b silencing did not impact CD1a endocytic pathways
(data not shown). Note that there was a slight decrease in CD1d
presentation due to lentiviral transduction alone, consistent with
the results of others that viral infection itself canmodestly impact
CD1d presentation (Chen et al., 2006; Yuan et al., 2006). Subse-
quent experiments verified that Arl8b silencing reduced CD1d
presentation of aGal-aGalCer in multiple cell types including
DCs, B lymphoblastoid cells (C1R), CD1 transfected cells
(HeLa), and myelomonocytic cells (U937), suggesting that the
Arl8b pathway is likely to be common in many and possibly all
cell types.
To extend the evaluation to a second species, we examined
murine CD1d (mCD1d), which predominantly traffics through
lysosomal compartments. We identified shRNAs targeting
murine Arl8b that were distinct from those against human
Arl8b. We next transduced RAW macrophages with lentivirus
encoding these shRNAs and measured dose response curves
to aGal-aGalCer. Consistent with findings for human CD1d,
silencing of murine Arl8b led to more than a two-log decrease
in dose-dependent mCD1d presentation in RAW macrophages
and 39% maximal stimulation of NKT-Cell hybridomas at the
highest concentrations of antigen dose tested (Figure 1C).
To verify that the shRNA sequences reduced Arl8b mRNA
expression, we performed reverse transcriptase-polymerase
chain reaction (RT-PCR) with Arl8b-specific primers. Arl8b
targeting shRNA reduced expression of the target by 74%
(Arl8b-346) and 85% (Arl8b-407) for human Arl8b and 85%
(Arl8b-461) and 90% (Arl8b-404) for murine Arl8b, respectively,
although they did not lead to changes in mRNA amounts of other
Arls tested (e.g., Arl8a, Arl2, and Arl13b). Further, we raised a
rabbit antiserum against the C-terminal peptide of Arl8b to
assess Arl8b protein amounts by western blotting. Because
human and murine Arl8b are 100% identical in amino acid
sequence, the same antiserum was used for detecting Arl
proteins of both species. The antiserum recognized a single
dominant band in human U937 cell lysates that was reduced
by >95% upon Arl8b silencing. The antiserum recognized
a doublet in RAW macrophages of which the dominant lower
band, equivalent in migration to the band observed in U937,184 Immunity 35, 182–193, August 26, 2011 ª2011 Elsevier Inc.was also specifically reduced (Figures 1D and 1E). Overexpres-
sion of Arl8b cDNA led to a dramatic increase in a band of the
same mobility confirming its identity as Arl8b (data not shown).
Even when silencing the intended target, RNA interference
approaches can give false-positive results through off-target
effects. To address this caveat, we generated a panel of unique
shRNAs targeting Arl8b along the length of the transcript, with
the reasoning that multiple unique sequences were unlikely to
have similar off target effects. A panel of six distinct shRNA
hairpins all produced reductions in Arl8b mRNA and CD1d
presentation by U937 cells (Figure S1). In a second approach,
HeLa cells were transduced with Arl8b shRNA and subsequently
transfected with Arl8b cDNA containing silent mutations gener-
ating a 6/21 mismatch to the Arl8b shRNA. We found that
reintroduction of Arl8b via cDNA expression corrected the defect
in HeLa CD1d presentation, further confirming that the observed
phenotypes were due to an on-target effect specific to Arl8b
silencing (Figure 1F).
Arl8b Silencing Induces a Defect in Cargo Delivery
to Lysosomes
Arl GTPases localize to specific subcellular compartments and
help to define organelle identity and direct organelle traffic.
Staining with Arl8b antiserum localized endogenous Arl8b to
lysosomal associated membrane protein-1 (LAMP1)+ lysosomes
(Figures S2A and S2B). Given the profound decrease in CD1d
antigen presentation observed in Arl8b silenced cells (Figures
1B and 1C) and the importance of trafficking to the lysosome
as a key step in antigen presentation, we hypothesized Arl8b
might control traffic into lysosomes. To address this possibility
we utilized fluorophore conjugates of dextran, a carbohydrate
molecule taken up into cells by fluid phase pinocytosis. Arl8b-
silenced and control cells were pulsed with an Alexa Fluor 546
(red) conjugate of dextran followed by a long chase (>6 hr) to
allow dextran to traffic to and accumulate in lysosomes. Cells
were then pulsed with a dextran molecule conjugated to a
second color (Alexa Fluor 488 green) and the amount of colocal-
izationwith the first dextran (red) assessed over time via confocal
microscopy (Figure 2A, left panels). Arl8b-silenced cells showed
a 56% reduced colocalization of the two dextrans when
compared with control cells at 30 min following pulse of Alexa
Fluor 488 dextran and 51% reduced colocalization at 60 min
following the pulse, indicating a delay in fluid phase cargo traf-
ficking into lysosomes (Figure 2B, top panel).
To extend these findings to cargo taken up by receptor
mediated endocytosis, we assessed the delivery of DiI-labeled
LDL (3,30-dioctadecylindocarbocyanine-low density lipoprotein)
molecules to lysosomes. After uptake by the LDL-R (LDL
receptor), LDL disassociates from LDL-R. Whereas LDL-R re-
cycles back to the cell surface, LDL continues trafficking to lyso-
somes. Lipid antigens such as a(1 > 2)GalaGalCer are also
taken up into cells through binding LDL-R and probably follow
a LDL-directed trafficking route to lysosomes (van den Elzen
et al., 2005). To assess this pathway, we prelabeled lysosomes
of Arl8b silenced and control cells with a pulse of Alexa Fluor
488 (green) dextran and then with a chase (chase time > 4 hr).
We subsequently serum starved cells for >2 hr to allow LDL-R
to accumulate on the cell surface and to synchronize LDL
uptake. A DiI-LDL pulse in serum-free media was given to cells
Figure 2. Arl8b Silencing Results in Delayed Delivery of Dextran and LDL to Lysosomal Compartments
(A) Lysosomes of Arl8b-silenced and control RAW cells were labeled with dextran (Alexa Fluor 546, red) pulsed for 60 min and then underwent a >6 hr chase to
allow accumulation in lysosomes (left). Cells were then incubated with a second dextran (Alexa Fluor 488, green) for various times (10 min, 30 min, 60 min) and
colocalization of both dextrans was assessed (right). Alternatively, cells were prelabeled for 30 min with transferrin (Alexa Fluor 546) to mark early endocytic
compartments and were subsequently pulsed with dextran (Alexa Fluor 488) in the continued presence of transferrin for short time points (5 min, 10 min, 30 min).
Shown are representative images for 30 min of dextran/ dextran pulse (left panels) and 10 min of dextran/ transferrin pulse (right panels).
(B) Colocalization quantification for >20 cells for each condition at each time point are shown for dextran/ dextran pulse (top panel) at 10min, 30min, and 60min
and dextran/ transferrin pulse (bottom panel) measured at 10 min.
(C) LysosomesofArl8b silenced andcontrol cellswereprelabeledwithdextran (Alexa Fluor 488, 1 hr pulse followedby6hr chase). Cellswere subsequently starved
in serum-freemedium for 2 hr and then incubatedwithDiI-LDL (red) for up to 30min. The 60min timepoint represents 30min of pulse followed by 30min of chase in
serum-free medium. Representative images from 60 min are shown.
(D) Colocalization quantification of DiI-LDL with dextran in Arl8b-silenced and control cells. All error bars indicate standard error of the mean. See also Figure S2.
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the colocalization of DiI-LDL with lysosomal dextran was as-
sessed (Figures 2C and 2D). At 30 min after the DiI-LDL pulse,
colocalization was reduced by 52% in Arl8b-silenced cells
compared to control cells, indicating a delay in arrival of LDL to
lysosomal compartments. A similar delay was noted for the
arrival of antibody-bound CD1d molecules to lysosomes in
Arl8b-silenced cells (Figure S2C). Together, these experimentssuggest that Arl8b plays an important role in delivery of multiple
types of cargo to lysosomes.
In contrast to the effects of Arl8b on trafficking to lysosomes,
trafficking through early recycling endosomes assessed by the
transient colocalization of dextran with the early endocytic
marker transferrin receptor (TfR) and total transferrin uptake by
TfR were unaffected in Arl8b-silenced cells (Figure 2A, right
panels and Figure 2B, bottom panel). Thus, the trafficking defectImmunity 35, 182–193, August 26, 2011 ª2011 Elsevier Inc. 185
Figure 3. Arl8b Silencing Does Not Alter the Recruitment of Rab7
or Its Effectors to Lysosomes
Control or Arl8b-silenced HeLa cells were transfected with the indicated
constructs (left panels), plated on glass coverslips, fixed, permeabilized, and
stained for LAMP1 (middle panels). Merged images are shown (right panels).
(A) Colocalization betweenRab7-GFP and LAMP1 in control cells (top row) and
Arl8b-silenced cells (bottom row).
(B) Colocalization between RILP-GFP and LAMP1 in control cells (top row) and
Arl8b-silenced cells (bottom row).
(C) Colocalization between GFP-ORLP1 and LAMP1 in control cells (top row)
and Arl8b-silenced cells (bottom row).
(D) Distribution of the dynactin motor subunit p150 in control cells (left) and
Arl8b-silenced cells (right).
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stream of transferrin receptor-positive early endocytic compart-
ments. In contrast to a delay in trafficking, Arl8b-silenced cells
did not display changes in lysosomal acidification compared to
control cells, nor did they display differences in the steady-state
localization of several markers in lysosomes (saposins,
cathepsin D, Rab9, Figure S2D).
Additionally, we confirmed previous reports implicating Arl8b
in the distribution of lysosomes within the cell (Figure S3A). The
distribution of lysosomes correlated with combined expression
of both Arl8a and Arl8b (Figure S3B). However, Arl8 double-
silenced cells appeared to be morphologically unhealthy in light
microscopy so we continued to focus studies on Arl8b-silenced
cells rather than Arl8 double-silenced cells.
Arl8b Silencing Does Not Alter the Recruitment of Rab7
or Its Effectors to Lysosomes
The small GTPase Rab7 directs trafficking from late endosomes
into lysosomes through the recruitment of the effector RILP
(Rab7 interacting lysosomal protein) (Cantalupo et al., 2001).
In turn, the Rab7-RILP complex binds p150, a subunit of
a dynein-dynactin motoring apparatus (Johansson et al., 2007).
This step is regulated in part by the oxysterol binding protein
ORP1L (Rocha et al., 2009). The Rab7,RILP,ORP1L,p150
complex drives movement toward the minus end of microtu-
bules. Therefore, changes in expression of Rab7 or its effectors
functionally impacts trafficking into lysosomes through control of
lysosomal localization. Given our identification of a role for Arl8b
in directing both traffic into lysosomes (Figure 2) and the localiza-
tion of lysosomes (Figure S3), we designed experiments to
determine if Arl8b might function through the recruitment of
Rab7 or its effectors to lysosomes. Arl8b-silenced and control
cells were transfected with Rab7-green fluorescent protein
(GFP), plated on glass coverslips, fixed, and analyzed for the
distribution of LAMP1 and Rab7. In control cells, Rab7 localized
almost exclusively to LAMP1+ vesicles (Figure 3A, top row).
Similarly, in Arl8b-silenced cells Rab7 continued to colocalize
strongly with LAMP1 even though lysosomes were redistributed,
indicating that Arl8b is not required for localization of Rab7 to
lysosomes (compare right panels, Figure 3A). Rab7 recruits
a subset of RILP molecules to late endosomes. Both control
and Arl8b-silenced cells displayed similar amounts of RILP
recruitment to lysosomes as measured by colocalization of
GFP-RILP with LAMP1 (compare right panels, Figure 3B). Like-
wise, recruitment of ORP1L molecules to LAMP1+ lysosomes
appeared unchanged in Arl8b-silenced cells when compared
to control cells (Figure 3C). Arl8b silencing also did not alter
the distribution of p150, the dynein-dynactin motor bound by
Rab7-RILP (Figure 3D). Together, these data suggest that
Arl8b does not direct lysosomal trafficking by controlling the
localization of Rab7 to lysosomes or its function in recruiting
effectors to this compartment. Rather, Arl8b is likely to function
through other effectors.
Arl8b Recruits the HOPS Complex Member VPS41
to Lysosomes
To discover effectors of Arl8b, we conducted biochemical
pull-downs with GST-Arl8b (glutathione- S-transferase-tagged
Arl8b) and identified candidate Arl8b effectors through mass186 Immunity 35, 182–193, August 26, 2011 ª2011 Elsevier Inc.spectrometry. A list of Arl8b interacting proteins is given in Fig-
ure S4. Strikingly, we identified peptides corresponding to
mammalian orthologs of the Saccharomyces cerevisiae HOPS
complex. In yeast, the HOPS complex is composed of six
subunits that together regulate all trafficking into the yeast
vacuole (Figure 4A) (Nickerson et al., 2009). Four of these
subunits, VPS11, VPS16, VPS18, and VPS33, constitute a core
complex termed VPS-C. In mammalian cells, both VPS-C and
VPS39may be sharedwith early endocytic trafficking complexes
Figure 4. Arl8b Recruits the HOPS Complex
Member VPS41 to Lysosomes
(A) Adapted from Nickerson et al. (2009).
Proposed subunits of the mammalian HOPS
complex based on orthology to S. cerevisiae. The
VPS-C core is composed of hVPS11, hVPS18,
hVPS16, and hVPS33. In yeast, VPS39 and VPS41
combine with VPS-C to form HOPS. The HOPS
complex regulates trafficking to lysosomes in
S. cerevisiae.
(B) Lysates from HeLa cells transfected with
HA-VPS41 were run over glutathione-conjugated
beads bound to GST (lane 2), GST-Arl8b (WT, lane
3), GST-Arl8b-Q75L (dominant-active mutant,
lane 4), GST-Arl8b-T34N (dominant negative
mutant, lane 5) and immunoblotted anti-HA.
Equal amounts of lysate were run on a separate
SDS-PAGE gel stained with Coomassie Brilliant
Blue for total protein detection.
(C) Yeast two-hybrid analysis. Arl8b, dominant-
active Arl8b Q75L, and p53 were cloned into
the DNA-binding domain vector (Matchmaker,
Clonetech). VPS41, SV40-T, VPS39, and VPS18
were cloned into the activation domain vector.
Yeast were plated on nonselective medium (+His)
to confirm viability and plated on selectivemedium
(His) to detect interactions.
(D) Interaction of Arl8b with VPS41 in two-protein
system. Purified Histadine-tagged Arl8b (shown
by Coomassie stain, middle) was immobilized on
a cobalt-resin column and exposed to purified
GST (lane 1), GST-VPS41 (lane 2), or GST-RILP
(lane 3) (shown by silver stain, bottom). Eluates
were run on SDS-PAGE and blotted anti-GST.
(E) Control (top row), Arl8b-silenced (middle row),
and Arl8b-overexpressing (bottom row) HeLa
cells were transfected with HA-VPS41 and an-
alyzed in confocal microscopy for the distribution
of VPS41 to LAMP1+ compartments. For a list of
GST-Arl8b interacting proteins identified, see also
Figure S4.
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et al., 2009). Thus, we initially determined whether Arl8b directed
trafficking to lysosomes by binding and recruiting mammalian
VPS41. Cells were transfected with HA-VPS41 (hemagglutinin-
tagged VPS41) and lysates were passed over glutathione
beads bound to either GST alone or GST-Arl8b. Eluates were
resolved on SDS-PAGE, immunoblotted for HA-VPS41, and
Coomassie stained (Figure 4B, lanes 1–3). GST-Arl8b bound
VPS41 whereas GST did not (compare strength of band in
lane 3 to those in lanes 1 and 2). Because Arl8b is a GTPase, it
cycles between active GTP-bound and inactive GDP-bound
forms. Previously, both a dominant-active GTP-locked form of
Arl8b (Arl8b-Q75L) and a dominant-negative GDP-locked form
of Arl8b (Arl8b-T34N) have been described (Hofmann and
Munro, 2006; Okai et al., 2004). Pull-down with GST-Arl8b-
Q75L confirmed that dominant-active Arl8b promoted interac-
tion with VPS41 (Figure 4B, note increase in intensity of VPS41
band in lane 4 compared to lane 3). Conversely, GST-Arl8b-
T34N negated the interaction with VPS41 compared to GST-
Arl8b-WT and GST-Arl8b-Q75L (Figure 4B, compare loss ofstrength of VPS41 band in lane 5 to those in lanes 4 and 3). These
data argue that Arl8b binds VPS41 in manner dependent on its
GTP versus GDP bound state, suggesting VPS41 is an effector
of Arl8b.
To determine whether Arl8b bound VPS41 directly, we under-
took two approaches. In the first, both Arl8b and HOPS complex
members were cloned into DNAbinding and transcription activa-
tion domain vectors, respectively, in standard yeast two-hybrid
complementation systems. All strains were viable as evidenced
by their growth on nonselective media (Figure 4C, rows 1, 2,
and 5 ‘‘+His’’). Both WT Arl8b and dominant -active Arl8b
(Q75L) bound VPS41, as evidenced by their growth on selective
media (Figure 4C, row 3 ‘‘–His’’). In contrast, Arl8b did not bind
VPS39 or VPS18 as evidenced by the failure of growth in selec-
tivemedia (Figure 4C, row 6 ‘‘–His’’). As expected, p53 bound the
positive control SV40-T but did not bind VPS41 (Figure 4C, rows
3 and 4). Together, these data argue that Arl8b specifically binds
VPS41. To confirm this finding, we expressed and purified
Histadine-tagged Arl8b (His-Arl8b), GST-tagged VPS41, and
GST bound to the Rab7 binding domain of RILP (GST-RILP).Immunity 35, 182–193, August 26, 2011 ª2011 Elsevier Inc. 187
Figure 5. Other Components of the HOPS
Complex Are Recruited to Lysosomes by
Arl8b and hVPS41
(A) Control HeLa cells (top row) were transfected
with hVPS18 and Arl8b, fixed, and stained for
hVPS18 (left) and Arl8b (middle). In themiddle row,
cells were transfected with hVPS41 (middle, Arl8b
staining at right) in addition to hVPS18. In the
bottom row, Arl8b-silenced HeLa cells were
transfected with hVPS18 (left), hVPS41 (middle)
and Arl8b (right), fixed, and stained. Similar data
were obtained with VPS11 and VPS16 (Figure S5).
(B) Similar to Figure 2C, lysosomes of hVPS41
silenced cells were prelabeled with dextran
conjugated to Alexa Fluor 488 (green). Cells were
then starved to allow LDL-R to accumulate, pulsed
with DiI-LDL (red) for 15 min, and chased in DiI-
LDL free medium for varying times, and the traf-
ficking of LDL to lysosomes was assessed by
colocalization with dextran. Shown are represen-
tative images of LDL trafficking to lysosomes after
90 min of chase time in control cells (top row) and
hVPS41-silenced cells (bottom row).
(C) Quantification of the colocalization between
dextran (green) and LDL in control and hVPS41-
silenced cells was performed for >30 cells at each
indicated time point.
(D) Indicated HOPS complex members were
stably silenced by shRNA treatment in CD1d+
U937 cells as described (see Experimental
Procedures). Cells were then pulsedwith 70 ng/mL
aGal-aGalCer, 50,000 NKT cells (J3N.5) added,
and the combination was incubated overnight.
Stimulation of NKT-cells was assessed by IFN-g
cytokine Elisa. A list of targeting shRNA sequences
is given in the Supplemental Information. All
error bars indicate standard error of the mean.
See also Figure S5.
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Arl8b Directs Cargo Delivery to LysosomesHis-Arl8b was immobilized on cobalt resin and incubated
with GST, GST-VPS41, and GST-RILP. Eluates were run on
SDS-PAGE and immunoblotted for GST. We found Arl8b-bound
VPS41 (lane 2) but did not bind either GST (lane 1) alone or
GST-RILP (lane 3) (Figure 4D, upper blot). These experiments
demonstrate that Arl8b directly binds VPS41.
To determine whether Arl8b recruits VPS41 to lysosomes, we
examined the distribution of VPS41 in control, Arl8b-silenced,
and Arl8b-overexpressing cells (Figure 4E). In control cells,
VPS41 showed partial colocalization with LAMP1, indicating
that a subset of VPS41 molecules was present on lysosomes
(Figure 4E, first row, right panel). However, in Arl8b-silenced cells
no colocalization between VPS41 and LAMP1 was detected
(Figure 4E, second row, right panel). This suggests that VPS41
is not recruited to lysosomes in the absence of Arl8b.
Conversely, overexpression of Arl8b led to a dramatic recruit-
ment of VPS41 to Arl8b+ LAMP1+ lysosomes (Figure 4E, third
row). Together, these data argue that Arl8b controls the localiza-
tion and recruitment of the HOPS complex member VPS41 to
lysosomes and that VPS41 is a direct effector of Arl8b.188 Immunity 35, 182–193, August 26, 2011 ª2011 Elsevier Inc.Arl8b and VPS41Recruit Other HOPSComplexMembers
to Lysosomes
VPS-C subunits of the HOPS complex did not show appreciable
localization to LAMP1+ lysosomes when HA-tagged versions
were expressed in cells (Figure 5A, Figure S5, and data not
shown). Instead, they primarily localized to the cytosol with
partial distribution to LAMP1 negative punctae. Overexpression
of Arl8b alone led to only slight changes in the distribution of
VPS-C molecules. However, when both Arl8b and hVPS41
were expressed in cells, VPS18 showed a dramatic recruitment
to lysosomes (Figure 5A, middle row), suggesting that Arl8b acts
together with VPS41 to promote the recruitment of VPS18.
Further, in Arl8b-silenced cells the localization of both VPS41
and VPS18 to lysosomes was lost, suggesting that recruitment
of HOPS complex members to lysosomes depends on Arl8b
(Figure 5A, bottom row). Similar data were obtained for VPS11
and VPS16 (Figure S5). Together, these data support a model
in which Arl8b primarily recruits VPS41, and together Arl8b and
VPS41 promote recruitment of the other HOPS complex
members to lysosomes.
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into the Mammalian Lysosome
Because HOPS complex members are known to direct traf-
ficking to the yeast vacuole, we assessed whether loss of
HOPS impacted trafficking to the mammalian lysosome. As in
Figures 2C and 2D, lysosomes of VPS41-silenced or control
cells were prelabeled with dextran and pulsed with LDL. After
chase, arrival of LDL in lysosomes was assessed through coloc-
alization with dextran. Similar to results for Arl8b-silenced cells,
we found VPS41-silenced cells displayed a dramatic delay in
delivery of LDL to lysosomes when compared to controls (Fig-
ure 5B, images, Figure 5C, quantification).
To assess whether loss of the HOPS complex recruited by
Arl8b resulted in a functional defect in CD1d presentation, we
took advantage of our trafficking shRNA library that contained
sequences directed against HOPS complex members. Multiple
unique shRNA sequences targeting HOPS gave reductions in
CD1d antigen presentation compared to control sequences (Fig-
ure 5D). In particular, shRNA sequences targeting VPS33A gave
strong reductions in CD1d presentation of aGal-aGalCer and
were among the strongest hits in the trafficking library. Together,
these data suggest that Arl8b recruits theHOPScomplex to lyso-
somes, which in turn directs cargo trafficking into this compart-
ment with consequences for CD1d antigen presentation.
Arl8b Silencing Leads to a Delay in Lipid Antigen Binding
to CD1d and Delivery of Antigen-Bound Complexes
to the Cell Surface
A delay in trafficking into lysosomes in Arl8b- or HOPS-silenced
cells might lead to a delay in the formation of CD1d,aGalCer
complexes for immune recognition by NKT-cells. To examine
the formation of CD1d,aGalCer complexes directly, we utilized
a monoclonal antibody (L363) that specifically recognizes the
CD1d,aGalCer complex but not CD1d without this bound
antigen or CD1d bound to unprocessed aGal-aGalCer (Yu
et al., 2007). Cells were coculturedwith 500 ng/mL aGal-aGalCer
and examined in confocal microscopy with mAb L363 and anti-
LAMP1 for assessment of the formation of CD1d,aGalCer
complexes intracellularly. Eight hours after aGal-aGalCer cocul-
ture, CD1d,aGalCer complexes could be detected in lysosomes
of control cells, whereas they were largely absent in Arl8b
silenced cells (data not shown). This difference was even more
pronounced 24 hr after coculture with aGal-aGalCer, indicating
that the defect in cargo delivery to lysosomes was mirrored by
a defect in CD1d,aGalCer complex formation in lysosomes (Fig-
ure 6A). Cells were also examined after a short pulse of aGal-
aGalCer at higher concentration (2.5 mg/mL for 2 hr) followed
by a chase. Arl8b-silenced cells showed only 34%staining inten-
sity of control cells at 1 hr and 21% staining intensity of control
cells at 12 hr after aGal-aGalCer pulse-chase (Figures 6B and
6C), confirming the delay in formation of CD1d,aGalCer
complexes.
The delay in formation of CD1d,aGalCer complexes intracellu-
larly in Arl8b-silenced cells could lead to a corresponding delay
in their delivery to the cell surface and a reduction in
CD1d,aGalCer-restricted NKT cell stimulation, explaining the
defect in CD1d antigen presentation observed in Arl8b- or
HOPS-silenced cells. To assess this possibility, we cocultured
cells either with aGal-aGalCer for various times or with differingamounts of aGal-aGalCer for a fixed time and assessed the
appearance of CD1d,aGalCer complexes on the cell surface by
flow cytometry withmAb L363 (Figure 6D). After 26 hr of coculture
with aGal-aGalCer, Arl8b-silenced cells showed only 57% of the
cell surface expression of CD1d,aGalCer complexes as
compared to control cells (Figure 6E, upper panel). Increasing
the amount of aGal-aGalCer administered did not overcome this
defect (Figure 6E, lower panel, e.g., Arl8b-silenced cells show
only 56% the mean fluorescence intensity (MFI) of control cells
at 1250 ng/mL aGal-aGalCer). This defect was specific to
CD1d,aGalCer complexes because amounts of mCD1d itself on
the cell surface did not change during the experiment in either
control or Arl8b-silenced cells. When cells were assessed with
a short pulse of high concentration antigen followed by 4 or 9 hr
of chase time (6 and 11 hr total time), Arl8b-silenced cells showed
50%of the MFI of control cells when stained for CD1d,aGalCer
complexesbyflowcytometry, confirming the resultsobtainedwith
continuous pulses of aGal-aGalCer (Figure 6F). Together, these
results suggest that the delay in trafficking into lysosomes leads
to a delay in the formation of CD1d,aGalCer complexes in lyso-
somes and a subsequent delay in their appearance at the cell
surface.
Arl8b Silencing Leads to a Delay in LAMP1 Appearance
on Phagosomes and a Defect in Microbial Killing
In order for microbial killing to occur, phagosomes must ma-
ture into phagolysosomes through content exchange with lyso-
somes. Given our findings that Arl8b plays a critical role in
directing the trafficking of endocytosed cargo to lysosomes,
we reasoned it might also mediate the trafficking of phagocy-
tosed cargo to lysosomes. First, the phagocytosis of microbes
was modeled with latex beads coated with IgG. Arl8b-silenced
and control cells were plated on glass coverslips, latex beads
added, and then centrifuged to synchronize bead uptake. Cells
were fixed, permeabilized, stained for LAMP1 and IgG, and
analyzed by fluorescence microscopy. Over time, phagosomes
containing latex beads fuse with lysosomes resulting in LAMP1+
‘‘rings’’ forming around the beads as the phagosomes mature
into phagolysosomes. A striking reduction in LAMP1+ staining
intensity in rings surrounding beads occurred in Arl8b-silenced
RAW cells compared with beads in control cells (Figure 7A).
For further verification that bead phagosomes were not fusing
with lysosomes in Arl8b-silenced cells, injested bead-phago-
some complexes were repurified from cells and analyzed for
acquisition of lysosomal markers by flow cytometry (Hmama
et al., 2004). Sixty minutes after adding beads, bead phago-
somes isolated from Arl8b silenced RAW revealed 49% of the
LAMP1 MFI as control cell bead phagosomes (Figure 7B).
Thus, acquisition of a lysosomal marker indicative of phagosome
fusion with lysosomes is delayed upon Arl8b silencing. Impor-
tantly, acquisition of transferrin receptor on bead phagosomes
was not affected by Arl8b silencing, again suggesting the traf-
ficking defect occurred downstream of the early endocytic
system (Figure S6B). Treatment with the actin polymerization
inhibitor cytochalasin D blocked the acquisition of LAMP1 on
latex beads and eliminated differences between Arl8b-silenced
and control cells, suggesting LAMP1 acquisition on beads was
due to a phagocytic process requiring actin reorganization and
was not nonspecifically acquired during bead purificationImmunity 35, 182–193, August 26, 2011 ª2011 Elsevier Inc. 189
Figure 6. Arl8b-SilencedCellsShowDelayed
Formation of CD1d,aGalCer Complexes
(A) Arl8b-silenced and control RAW cells were co-
cultured with 500 ng/mL aGal-aGalCer for 24 hr,
costained with L363 (CD1d,aGalCer complex
specific) and LAMP1 mAbs, and analyzed by
confocal microscopy.
(B) Cells were pulsed with 2.5 mg/mL aGal-aGalCer
for 2 hr and then underwent a washout and
replacement with fresh medium (‘‘chase’’). Re-
presentative images are shown for 1 hr of chase.
(C)QuantificationofCD1d,aGalCer staining for >30
Arl8b-silenced and control cells at the indicated
time points. The average pixel intensity for
CD1d,aGalCer staining per cell was divided by the
average LAMP1 pixel intensity for the same cell to
normalize. Error bars indicate the standard error of
the mean.
(D) Arl8b-silencedandcontrol cellswerecocultured
with 500 ng/mL aGal-aGalCer for 0 (left panel) or 12
(right panel) hr and CD1d,aGalCer complexes at
the cell surface were analyzed by flow cytometric
staining with mAb L363.
(E) Arl8b-silenced and control cellswere cocultured
either with 500 ng/mL aGal-aGalCer for increasing
amounts of time (upper panel) or for 12 hr with
increasing concentrations of aGal-aGalCer (lower
panel), and CD1d,aGalCer complexes at the cell
surface were analyzed. Mean fluorescence inten-
sities (MFIs) relative to time 0 were plotted for
staining with L363 mAb.
(F) Instead of continuous coculture, Arl8b-silenced
and control cells were pulsed with 2.5 mg/mL aGal-
aGalCer for 2hr and thenchased incompletemedia
for 1 hr, 4 hr, and 9 hr. The appearance of
CD1d,aGalCer complexes at the cell surface was
monitored by L363 flow cytometric staining and
MFIs plotted.
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Arl8b Directs Cargo Delivery to Lysosomes(Figure S6A). Together, these data suggest that Arl8b silencing
leads to a defect in the interaction of lysosomes with latex
bead phagosomes and a subsequent delay in forming
phagolysosomes.
To extend these findings to live organisms, we utilized a path-
ogenic Escherichia coli strain expressing GFP. E. coli GFP were
opsonized through binding of mouse serum, added to Arl8b-
silenced or control RAW cells plated on glass coverslips, and
infection synchronized by centrifugation of the bacteria onto
the cells. RAW cells were then fixed, permeabilized, and
analyzed for GFP (E. coli) and LAMP1 (lysosomes) in fluores-
cence microscopy. In control cells, LAMP1 accumulated around
intracellular E. coli (Figure 7C, upper panels). In contrast, Arl8b-
silenced RAW cells showed multiple intracellular E. coli with no
surrounding LAMP1 (Figure 7C, lower panels). Further, E. coli
GFP appeared brighter in Arl8b-silenced cells consistent with
less degradation of the microbe and GFP. To directly measure
intracellular killing of the microbe, we infected Arl8b-silenced190 Immunity 35, 182–193, August 26, 2011 ª2011 Elsevier Inc.or control cells with E. coliGFP as above,
and at various times after infection viable
E. coli were recovered through gentle
detergent cell lysis. The detergent lysis
disrupted RAW cell membranes but didnot negatively impact E. coli viability, allowing assessment of
the live bacteria remaining as colony forming units (CFUs).
Arl8b-silenced cells showed at least twice as many viable
bacteria as control cells at 30min and 90min after infection, indi-
cating a defect in microbial killing (Figure 7D).
Taken together, our results show that Arl8b directs trafficking
into lysosomes through recruitment of the HOPS complex,
directs the intersection of CD1d with lipid antigens in lysosomes,
and plays a role in intersecting phagosomes with lysosomes to
generate phagolysosomes that kill microbes.
DISCUSSION
The function of Arl proteins is just beginning to be understood.
Arl1 localizes to the trans-Golgi, where it binds a large coiled-
coil protein termed a Golgin that functions as a molecular tether
for incoming vesicles (Burguete et al., 2008; Munro, 2005). Thus,
Arl1 is thought to mediate vesicle traffic entering the trans-Golgi.
Figure 7. Arl8b Silencing Delays Fusion of
Phagosomes with Lysosomes Leading to
a Defect in Microbial Clearance
(A) Control or Arl8b silenced RAW cells were
plated on glass coverslips and then centrifuged
with 3 mm IgG-coated latex beads for 0 min,
15 min, 30 min, 60 min, and 120 min. Cells were
fixed and stained for LAMP1 (red) or IgG (green).
Representative images for 60 min are shown.
Higher-power magnification (inset) is shown for
clarity.
(B) Arl8b-silenced and control cells were plated as
in (A) but without coverslips. Cells were disrupted
by repeated passage through a small-gauge
needle in a hypotonic lysis buffer, and latex bead-
containing phagosomes recovered. These were
then stained with LAMP1 antibody, analyzed via
flow cytometry, and LAMP1 MFI plotted against
time of bead incubation.
(C) Similar to (A), only cells were infected with
E. coli expressing a GFP plasmid at an MOI of 20.
Shown are representative images taken from 1 hr
after infection. On the right are high-magnification
images of intracellular E. coli from a control cell
(upper-right panel) and Arl8b-silenced cell (lower-
right panel).
(D) Similar to (C), however instead of fixation and
analysis by microscopy, RAW cells were lysed at
30 min and 90 min of chase time in gentamycin,
and live E. coli recovered through assaying CFU
on agar plates. Error bars indicate the standard
error of the mean. See also Figure S6.
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Arl8b Directs Cargo Delivery to LysosomesThe data presented here suggest that Arl8b may direct analo-
gous interactions for lysosomes through recruiting the HOPS
complex. In yeast, the HOPS complex interacts directly with
core vesicle fusion machinery. For example, VPS33 binds the
lipid PX domain of the vacuolar protein Syntaxin-7 that is consti-
tutively present on yeast vacuoles (Stroupe et al., 2006) but does
not exist in orthologous mammalian proteins (Nickerson et al.,
2009). It is possible that as evolution progressed from yeast
vacuoles to more complex lysosomes, interactions that once
were constitutive became regulated by networks of GTPases
such as Arl8b. Such regulation is probably critical for controlling
the fusion of lysosomes with late endosomes or phagosomes
through controlling the recruitment of HOPS, with consequences
for processes essential to mammalian organisms such as
antigen presentation and microbial defense. Interestingly, Arl8b
exhibits 100% conservation of polypeptide sequence among
multiple mammalian species and is among the most stably ex-
pressed genes across a variety of cell types, suggesting a strong
evolutionary pressure to maintain this important molecule (Kwon
et al., 2009). Furthermore, an Arl8b homolog that also mediates
cargo delivery to lysosomes inC. eleganswas identified recently
(Nakae et al., 2010).
Although our data suggest Arl8b does not affect recruitment of
Rab7 to lysosomes, we cannot rule out mechanisms in which
Rab7 functions upstream of Arl8b in trafficking. Previous data,
primarily in S. cervisiae, have implicated the GTPase Ypt7
(Rab7) in recruiting HOPS to late endosomes and have sug-
gested that VPS41 functions as an effector of Rab7 (Rink et al.,
2005). One model reconciling Rab7 recruitment of VPS41 with
the data presented here posits that Rab7 on late endosomesrecruits the HOPS complex, which in turn is recruited to lyso-
somes by Arl8b. In this wayHOPSwould directly bring late endo-
somes and lysosomes together for fusion, with Rab7 serving
as an organizing GTPase on late endosomes and Arl8b as an
organizing GTPase on lysosomes. Alternatively, Rab7 and
Arl8b present on the same vesicle may work cooperatively in
the recruitment of HOPS complex members in mammalian cells.
A recent report identifies Arl14 as a controller of MHC class II
transport along the actin cytoskeleton (Paul et al., 2011).
Together, these reports implicate the Arl family of GTPases as
critical regulators of vesicle traffic and immunological host
defense. Microbial infection is a constant tug-of-war between
host trafficking molecules directing antigen presentation and
microbial killing and the microbes themselves that seek to
evade these defenses. Mycobacterium tuberculosis, Legionella
pneumophila, Salmonella enterica, and many other microbes
are known to manipulate host trafficking GTPases of the Rab
and Arf families to avoid antigen presentation and microbial
killing (Flannagan et al., 2009; McGhie et al., 2009). Like Rabs
and Arfs, perhaps Arls may be targets of microbial immune
evasion strategies. Here, we have defined an important role for
Arl8b in cargo delivery to lysosomes for antigen presentation
and microbial killing suggesting that Arl8b has important roles
in a variety of cellular and immunological functions of lysosomes.EXPERIMENTAL PROCEDURES
Cell Lines and Reagents
U937 cells (ATCC) were cultured in RPMI 37C, 5% CO2 supplemented with
10% fetal bovine serum (Hyclone), L-glutaminse (2 mM), Pen-Strep, sodiumImmunity 35, 182–193, August 26, 2011 ª2011 Elsevier Inc. 191
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Arl8b Directs Cargo Delivery to Lysosomespyruvate, and b-mercaptoethanol (55 mm). The humanNKT cell clones BM2a.3
and J3N.5, as well as the murine NKT hybridoma DN32, were described previ-
ously and cultured in the same medium supplemented with essential amino
acids, nonessential amino acids, and HEPES (10 mM) (Brutkiewicz et al.,
1995; Vincent et al., 2002). For generating monocyte-derived DCs transduced
with shRNA, CD14+ peripheral blood monocytes from anonymous donors
(MACS isolation, Miltenyi Biotec) were cultured in granulocyte macrophage-
colony stimulating factor (GM-CSF) (300 U/mL) and interleukin-4 (IL-4) 200
(U/mL). RAW 264.7 macrophages (ATCC) were cultured in DMEM 37C,
10% CO2 with the above supplements. Alexa Fluor conjugate Transferrin
and Dextran were added at 10 mg/mL and .5 mg/mL in complete media unless
otherwise noted. DiI-LDL was used at 10 mg/mL.
shRNA
Please see Table S1 in Supplemental Information for a full listing of shRNA
sequences.
Lentiviral Production and Transduction
All lentivirus was produced in accordance with BL-2+ protocols publicly avail-
able at the Broad TRC website (http://www.broadinstitute.org/rnai/public/
resources/protocols). VSV-G, pLKO.1, and d8.9 plasmids were obtained
from the Broad RNAi Consortium. For further information, please see the
Supplemental Information.
Antigen Presentation and Cytokine ELISAS
For all assays, 50,000 antigen-presenting cells (U937, HeLa, RAW, C1R, DC)/
well were plated in 96-well flat-bottom plates (Corning) with the indicated
concentrations of aGal-aGalCer (Veerapen et al., 2009). After 2 hr, 50,000
responding T cells (J3N.5, BM2a.3, DN32)/well were added and incubated
together at 37C, 5% CO2. After 18–30 hr, supernatants were transferred to
CoStar High Binding Plates (Cat # 3369) for sandwich ELISA. Human IFN-g
ELISAs were performed with mAb pair M700A and M701B (Thermo) and
murine IL-2 ELISAs with mAb pair 554424 and 554426 (BD Biosciences).
Detection was done with Streptavidin-AlkPhos (554065, BD Biosciences)
and then with PNPP (N-2770, Sigma) and absorbance reading at 405 nm
(Molecular Devices).
RT-PCR and Immunoblotting
Total RNA was prepared with RNEasy and QIAshredder kits (QIAGEN) and
then underwent reverse transcription with QuantiTect (QIAGEN). qPCR was
performed w SYBR green (Agilent/Stratagene). See Table S2 for a complete
listing of all primer sequences used in qPCR. A rabbit antisera against the
C-terminal peptide of Arl8b N-TLQWLIQHSKSRRS-COOH was produced
(YenZym). For further details, please see the Supplemental Information.
Confocal Microscopy and Quantification
Cells were adhered overnight in complete medium to #1.5 coverslips and fixed
with 3% paraformaldehyde in 13 HBSS containing Ca2+ and Mg2+ for 20 min
at room termperature (RT) and then quenched with 50 mM NH4Cl in PBS for
10 min at RT. Permeabilization and antibody staining was done with 0.5%
BSA, 0.1% Saponin, in PBS. For staining with L363 (anti-CD1d,aGalCer
complex), a blocking step utilizing 10% goat serum was added. Cells were
mounted in 15% vinol 205, 33% glycerol in PBS and analyzed on a Nikon
TE2000-U inverted Microscope equipped with the laser scanning C1 confocal
system. Image analysis and quantification was done with MetaMorph
v7.6.4 (MDS Analytical Technologies). See Supplemental Information for
further details. All scale bars represent 10 mm.
GST Pull-downs
Please see Supplemental Information for details.
Flow Cytometry
Cells or latex beads were stained in flow cytometry buffer (2% FBS, 0.01%
sodium azide in PBS) with anti-LAMP1 at 5 mg/mL (553792 & 555798, BD),
anti CD1d 5 mg/mL (553843, BD), and lastly anti-Rat PE (Invitrogen). For
staining anti-CD1d,aGalCer (L363), 10,000 cells were first blocked with 10%
normal goat serum, stained with 300 ng/mL L363, and lastly stained with192 Immunity 35, 182–193, August 26, 2011 ª2011 Elsevier Inc.goat anti-mouse PE (Invitrogen). All samples were analyzed on a FACSort
flow cytometer (Beckton-Dickinson).
Phagosomal Assays
Please see Supplemental Information for details.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, three tables, and Supplemental
Experimental Procedures and can be found with this article online at doi:10.
1016/j.immuni.2011.06.009.
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